HIF1A and acute respiratory distress syndrome: Subsequent pharmacological studies using HIF activators or inhibitors revealed that HIF-1α stabilization attenuated pulmonary edema and lung inflammation during ALI, while treatment to inhibit HIF transcriptional activity resulted in increased susceptibility to lung injury [57].